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Abstract
Background: Group A Streptococcus pyogenes (GAS) exhibits a high degree of clinically relevant phenotypic diversity. Strains
vary widely in terms of antibiotic resistance (AbR), clinical severity, and transmission rate. Currently, strain identification is
achieved by emm typing (direct sequencing of the genomic segment coding for the antigenic portion of the M protein) or
by multilocus genotyping methods. Phenotype analysis, including critical AbR typing, is generally achieved by much slower
and more laborious direct culture-based methods.
Methodology/Principal Findings: We compare genotype identification (by emm typing and PCR/ESI-MS) with directly
measured phenotypes (AbR and outbreak associations) for 802 clinical isolates of GAS collected from symptomatic patients
over a period of 6 years at 10 military facilities in the United States. All independent strain characterization methods are
highly correlated. This shows that recombination, horizontal transfer, and other forms of reassortment are rare in GAS
insofar as housekeeping genes, primary virulence and antibiotic resistance determinants, and the emm gene are concerned.
Therefore, genotyping methods offer an efficient way to predict emm type and the associated AbR and virulence
phenotypes.
Conclusions/Significance: The data presented here, combined with much historical data, suggest that emm typing assays
and faster molecular methods that infer emm type from genomic signatures could be used to efficiently infer critical
phenotypic characteristics based on robust genotype: phenotype correlations. This, in turn, would enable faster and better-
targeted responses during identified outbreaks of constitutively resistant or particularly virulent emm types.
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Introduction
Group A Streptococcus pyogenes (GAS) is a common agent of
pharyngitis, febrile respiratory infection, and pneumonia. Less
frequently, it can cause severe symptoms such as toxic shock
syndrome, necrotizing fasciitis, and sterile rheumatic sequelae [1].
Penicillin is effective in treatment and prevention of GAS [2–4],
but other antibiotics are often required for individuals who are
allergic to penicillin [5]. Different strains of GAS differ widely in
terms of both AbR profiles and virulence [1].
GAS strains are commonly discriminated by identity of the M
protein, a primary antigen. Traditionally this has been done by
GAS culture and serological analysis of purified M protein, and can
distinguish 81 recognized M types [6]. Currently, this is usually
done by comparingthe sequence of a portion of the emm gene with a
database of sequences from previously identified strains ([6]; http:
//www.cdc.gov/ncidod/biotech/strep/protocol_emm-type.htm).
The two methods are highly concordant [6]. Sequence analysis
revealed new types, yielding over 200 currently recognized emm
types [7]. Multilocus sequence typing (MLST) has also been
explored, and found to be tightly correlated with emm typing [8].
The correlation between emm gene identity and the sequence of
several unrelated MLST loci suggests a high degree of genomic
stability within this bacterial species. This is also supported by
previously reported associations between AbR profile and emm
type (eg, [9]) and specific correlations between virulence and emm
type (eg, [10]). This supports exploration of rapid genotyping
methods as tools for point-of-care identification of strains and
inference of antibiotic susceptibility, outbreak potential, and
virulence phenotypes.
One rapid, high-throughput GAS genotyping method has been
described. The method involves PCR of 6 housekeeping loci,
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of the resulting amplicons to yield nucleotide content data
(deduced from mass), and finally, comparison with data from
known emm types. This method has been used to identify GAS in
uncultured specimens from an outbreak in the United States [7].
That study also presented validation/control data collected on 132
previously isolated and cultured GAS strains of 17 different emm
sequence types from 5 recruit training centers collected in 2002
and 2003 [7]. PCR/ESI-MS yielded single emm type identifications
in approximately two thirds of the cases, and lists of two or more
equally likely emm types in the remaining cases (these groups of
equally likely emm types are hereafter referred to as emm groups).
Accuracy was extremely high, with all calls either matching (in the
case of single emm type calls) or including (in the case of emm group
calls) the sequence-derived emm type.
PCR/ESI-MS can be completed in less than 4 hours, and
several hundred specimens can be analyzed in a day using a single
instrument. Direct emm sequencing is significantly more difficult
and time-consuming, since it is usually done on cultured isolates to
decrease background and yield clean sequencing results—
procedures that take 1 or more days to complete. Direct
sequencing from original specimens is possible, but has not been
thoroughly explored.
We present AbR and PCR/ESI-MS emm group data from 802
clinical GAS isolates collected from patients with pharyngitis or
other apparent GAS-associated symptoms over a period of 6 years
at 10 US military facilities. The majority of these samples are from
military recruits in training, a group that is highly susceptible to
GAS outbreaks and regularly prophylaxed with long-acting
penicillin G (bicillin).
Accuracy of PCR/ESI-MS emm grouping identification is
addressed by comparison with emm sequence data for 387 isolates.
We analyze several temporal/spatial clusters of specific emm groups
in their entirety to judge the potential for inference of specific emm
type from PCR/ESI-MS emm groups using emm sequence data
from a representative subset of samples. The associations between
specific AbR phenotypes and emm type (or emm group) are
statistically analyzed to quantify the degree of nonrandom
association between emm type and specific AbR phenotypes.
Observed correlations are compared to previously reported
associations. The relative predictive values of emm sequencing
and PCR/ESI-MS are discussed.
Outbreaks, rheumatic sequelae, and invasive GAS disease
generally involve only a few of the more than 200 known emm
types of GAS, and specific strains have been recognized as being
more virulent, with greater epidemic potential than other strains
[10–15]. M1 was associated with severe GAS infections and
streptococcal toxic shock syndrome during the mid-to-late1980s.
The relative dominance of M1 among strains isolated from
patients with uncomplicated pharyngitis was correlated with
changes in the rate of severe infections over time—that is, severe
GAS complications are more common when M1 is common [10].
The opposite was found to be true for M4 and M12, which are
associated with mild and uncomplicated pharyngitis [10]. More
recently, M3 was implicated in outbreaks of severe disease in both
the United States [7,13,16] and the United Kingdom [17].
Serotypes M1, 3, 5, 6, 18 and 24 have all been identified as
rheumatogenic, or capable of causing acute rheumatic fever
(ARF), and it has been suggested that the cyclic nature of severe
infection and ARF rates is a reflection of the cyclic circulation of
specific rheumatogenic serotypes [1].
While rheumatogenic strains are often distinguished by
serotype, it has been noted that the presence of the speA scarlet
fever toxin gene seems to be closely linked to rheumatogenic
characteristics. However, while many isolates of the most
notoriously virulent serotypes (M1 and M3) carry speA, others do
not [18]. Similarly, mucoid colony morphology has been linked to
rheumatogenicity, and can be variable within serotypes [10,13].
During the collection period represented in this study, there were
7 distinct outbreaks of GAS disease, as measured by sudden
increases in apparent rate. There were also 3 GAS-associated
fatalities. We specifically typed representatives of all outbreaks, as
well as all fatal case isolates, to determine if they were generated by
strains previously identified as having a high potential for virulence.
We also analyzed a representative subset of the identified emm types
from the isolate collection for speA by PCR [19].
Results and Discussion
PCR/ESI-MS correlates well with emm sequencing
Lists comparing the results of PCR/ESI-MS and emm
sequencing are shown in Tables 1 and 2. Of 387 sequenced
isolates, PCR/ESI-MS emm groups included the correct emm type
in 384 cases (99.2% accuracy). All three discrepancies involved
emm type 81 in some way, but each was a unique combination of
Table 1. Correlations between emm groups and emm types.
emm group emm type (N)
1 1 (23) 81 (1)
2 2 (10)
3 3 (66)
4 4 (16)
6 6 (1)
11 11 (13)
78 78 (1)
87 87 (4)
94 94 (2) 81 (1)
5/58 5 (58) 58 (6)
12/77 12 (15)
1/4/9/15/18/39/103/110/119 4 (1) 9 (2) 119 (1)
12/77/118 77 (10) 118 (16)
17/22/47/84 22 (6)
18/81/109 18 (13)
22/25/28/75 75 (1)
22/28 28 (16)
22/61/81/104 6( 1 )
25/75 75 (33)
29/53/91/101 29 (3)
36/77/82/85/96/103 85 (1)
52/93/101/104/116 101 (4)
6/22/50/62/81/104 6 (22)
68/75 68 (5) 75 (6)
73/81/90 73 (6)
75/78/89 89 (7)
9/44/61/82 44 (15) 82 (1)
emm types (identified by emm gene sequence analysis) associated with each
emm group (set of equally likely emm types, as identified by T-5000 PCR/ESI-MS
analysis); Contradictory identifications are shown in bold. All identities are
shown as ‘‘identity (number identified)’’ for that specific associative category.
doi:10.1371/journal.pone.0006897.t001
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type 81 in either the PCR/ESI-MS database or the GenBank
sequences used to determine emm type by the described sequencing
method. The precision of PCR/ESI-MS was significantly less than
that of direct sequence analysis, since the average emm group
included several equally likely emm types. Imprecision (multiplicity
of equally possible emm types in each emm group) ranged from 1 to
9, with a weighted average of 2.26 emm types per emm group across
the set of 387 sequenced isolates. However, not all of the possible
emm types were identified among the isolates: only 29 of the 200+
recognized emm types were identified in the sample set. Many of
these maintained a stable presence at specific sites, demonstrating
that specific emm types could be inferred across temporally and
geographically clustered sets using paired results from a subset that
had been tested by both methods.
At least one isolate of each emm group per year from each site
was sequenced. An additional 188 isolates from the same
geotemporal clusters were also sequenced, of which 187 confirmed
the initial correspondence, yielding a within-cluster consistency of
99.5%. In the single instance of inconsistency, all isolates from the
mixed emm group were sequenced, and all remaining isolates
shared the initially identified emm type. In some cases, specific emm
sequence types were identified across multiple emm groups, all of
which contained the correct emm type (for example, note the three
emm groups that were identified for emm 75 in Table 2). In these
cases, no phenotypic, geographic, or temporal correlates were
identified, suggesting that the differences resulted from variation in
the precision of the PCR/ESI-MS method.
Rapid genotyping methods can be used to confidently
predict both virulence and antibiotic resistance
Tables 3 and 4 show the distribution of AbR phenotypes among
the identified emm types (Table 3) and PCR/ESI-MS emm groups
(Table 4). These tables clearly show strong associations between
specific resistance phenotypes and specific genotypes. The overall
rates of AbR seen in the collection as a whole are shown in
Tables 5 and 6, along with the chi-square probability of the
observed distribution among emm types being random. Statistical
significance of individual emm type associations with specific
antibiotics is also indicated in Tables 3 and 4, for both positive and
negative associations. Both unadjusted and alpha adjusted
(Bonferroni adjusted) significance levels are indicated to represent
relative levels of confidence. The increased ambiguity yielded by
PCR/ESI-MS does not significantly decrease predictive values,
though it should be noted that this would not necessarily hold up
over longer periods of time, when serotypes sharing PCR/ESI-MS
emm groups could shift in relative dominance. This is because
multiple emm types represented by each emm group do not always
share phenotypes. For example, M25 and M75 share a PCR/ESI-
MS emm group. M25 is susceptible to erythromycin, and M75 is
generally resistant. The predictive value of this emm group, 25/75,
is high in this study, but only because M75 was far more common
than the phenotypically opposite M25. PCR/ESI-MS is readily
elaborated, and the designers have noted that it would take 12
primer pairs (as opposed to 6, as used here) to completely
distinguish all known emm types [7]. Furthermore, this technology
is amenable to a higher density multiplex format that could allow
many of these assays to be combined, thus enabling elaboration
without decreased throughput or additive increases in cost.
The data collected here correlate with past observations. For
example, we observed erythromycin resistance among isolates of
M4, M5, M6, M11, M12, M22, M44, M58, M75, and M94, with
the majority of resistance coming from M75. Other surveys of
GAS isolates in which both emm type and AbR type were analyzed
have suggested that macrolide (erythromycin) resistance in GAS is
strongly correlated with M4, M6, M12, and M75. M75 was
associated with over 50% of the macrolide resistance among
diverse US isolates collected between 1994 and 1997 [20], while
M6 was found to be associated with macrolide resistance among
isolates collected from Pittsburg schoolchildren [21]. Among
isolates collected from patients in Belgium, M6 was also the most
common source of macrolide resistance, but M2, M12, and M4
were also common [22]. M4, M12, and M75 were all commonly
associated with macrolide resistance in Greek isolates [23]. M4
and M75 were associated with 79% of all erythromycin resistance
seen among isolates collected from several cities over a decade in
Spain, followed closely by M12 [9]. Collectively, this demonstrates
a global and temporally robust association between erythromycin
resistance and a few specific strains.
Of the 7 noted outbreaks during the surveillance period, 1 (the
only one with high rates of pneumonia) was associated with M3
Table 2. Inverse relationships between emm groups and
emm types.
emm
type emm group (N)
1 1 (23)
2 2 (10)
3 3 (66)
4 1/4/9/15/18/39/103/110/119 (1) 4 (16)
5 5/58 (58)
6 6/22/50/62/81/104 (22) 22/61/81/104 (1) 6( 1 )
9 1/4/9/15/18/39/103/110/119 (2)
11 11 (13)
12 12/77 (15)
18 18/81/109 (13)
22 17/22/47/84 (6)
28 22/28 (16)
29 29/53/91/101 (3)
44 9/44/61/82 (15)
58 5/58 (6)
68 68/75 (5)
73 73/81/90 (6)
75 22/25/28/75 (1) 25/75 (33) 68/75 (6)
77 12/77/118 (10)
78 78 (1)
81 1 (1) 94 (1)
82 9/44/61/82 (1)
85 36/77/82/85/96/103 (1)
87 87 (4)
89 75/78/89 (7)
94 94 (2)
101 52/93/101/104/116 (4)
118 12/77/118 (16)
119 1/4/9/15/18/39/103/110/119 (1)
emm groups (set of equally likely emm types, as identified by T-5000 PCR/ESI-
MS analysis) associated with each emm type (identified by emm gene sequence
analysis); Contradictory identifications are shown in bold. All identities are
shown as ‘‘identity (number identified)’’ for that specific associative category.
doi:10.1371/journal.pone.0006897.t002
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associated with M5. The listed strains represented the majority of
isolationsintherespectiveoutbreaks,thoughotherstrains(including
M18, M77, M101, and M4) were also isolated during outbreak-
related collection activities. Two of the M5 outbreaks were
associated with some invasive disease, and two of the three noted
fatalities during the surveillance period were associated with M5.
The remaining fatality was associated with M77. This agrees with
previous identifications of M3 and M5 as particularly virulent emm
types, and demonstrates a strong correlation between emm type and
virulence. All M1 and M3 isolates tested in this study were speA
positive, and both types were very common. M5 was speA negative.
The speA gene has been implicated in invasive phenotypes. It is
interesting that the strain of M5 that became common during the
second half of the study period was negative by PCR for speA, yet
was strongly associated with both invasive and epidemic character-
istics. This behavior is similar to that of M5 in outbreaks in 1989
[13], and similar to what is expected of the common speA-positive
strains like M3 and M18 [11,13,16]. It is possible that this strain
derives its invasive potential from genes other than speA,o ri ti s
possible that the gene has mutated such that it yields a false negative
result for speA by PCR but still retains functional expression of the
SpeA protein. Correlational analysis of the data suggests the former
since most speA-negative emm types, including M5, are speC positive
(see Table 3), while most speA-positive types are speC negative.
Rapid genotyping methods yield GAS strain identifications that
are tightly associated with critical clinical characteristics, including
antibiotic resistance, virulence and outbreak potential (transmis-
sibility). Such methods, if applied directly to patient specimens at
the point of care, have the potential to offer clinically relevant
information useful for both determination of treatment and
identification of appropriate public health responses. We hope
that others will continue to contribute to the associative data sets
that will allow inferential use of such technologies, both for this
organism and for other important human pathogens.
A methodological shift from culture-based analyses toward less
laborious rapid antigen tests is happening quickly. However, these
tests do not offer any AbR data for treatment decisions or for
tracking resistance, nor do they offer genotype data useful for
tracking transmission and virulence patterns. The replacement of
traditional culture-based methods with on-site rapid diagnostic
methods should be made contingent upon development of equally
informative rapid technologies, or combined with archiving
programs that retain enough of the original specimen to allow
further characterization when necessary. Rapid multilocus geno-
typing methods preserve the value and power of culture-based
methods, while offering much greater speed and throughput.
Materials and Methods
Ethics statement
This research has been conducted in compliance with all
applicable federal and international regulations governing the
protection of human subjects in research (DoD IRB protocol
NHRC.2001.0008). This study was based entirely on the use of
deidentified isolates provided with minimal demographic data.
These isolates were already-existing, cultured from throat swabs
during the process of routine clinical diagnostic procedures at
recruit training sites. This protocol was reviewed and approved by
the NHRC institutional review board and found to be exempt
from consent requirements.
Sample collection
As part of the US military’s ongoing GAS surveillance program,
802 samples were collected at 10 military facilities from January
2002 through December 2007. Collection was irregular, based on
prevalence of and access to cases of GAS disease. Some sites
ceased submission after switching to rapid antigen tests and
abandoning culture methods.
Patients reporting to medical clinics with pharyngitis or other
apparent GAS-associated conditions were sampled by oropharyn-
geal swab. Swabs were streaked on blood agar plates using
Table 3. Isolate properties by sequenced emm type.
emm
type speA speC ERY CLI TET LEV CHL OFX
N+(N) N+(N) N+(N) N+(N) N+(N) N+(N) N+(N) N+(N)
1 13(13) 0(13) 0(23)
a 0(23) 0(23) 0(23) 1(16) 1(16)
101 0(1) 1(1) 0(4) 0(4) 0(4) 0(4) – –
11 0(9) 9(9) 1(13) 2(13)
a 0(13) 0(13) 0(12) 0(12)
118 0(16) 16(16) 0(16) 0(16) 0(16) 0(16) 0(9) 0(9)
119 0(1) 1(1) 0(1) 0(1) 1(1) 0(1) 0(1) 0(1)
12 0(9) 6(9) 2(15) 1(15) 0(15) 0(15) 0(9) 0(9)
18 1(9) 8(9) 0(13) 0(13) 0(13) 0(13) 0(1) 0(1)
2 0(5) 4(5) 0(9) 0(9) 0(9) 0(9) 0(6) 0(6)
22 0(3) 1(3) 1(6) 0(6) 0(6) 0(6) 0(6) 0(6)
28 0(10) 9(10) 0(16) 0(16) 0(16) 0(16) 1(11) 1(11)
29 0(3) 0(3) 0(3) 0(3) 0(3) 0(3) – –
3 12(12) 5(12) 0(66)
b 0(66) 0(66)
b 2(66) 8(50)
a 3(50)
4 0(11) 10(11) 2(17) 0(17) 0(17) 0(17) 0(6) 0(6)
44 0(7) 0(9) 1(15) 0(15) 1(15) 0(15) 3(12)
a 0(12)
5 0(31) 31(31) 1(58)
a 0(58) 1(58)
a 0(58) 6(33)
a 0(33)
a
58 0(6) 1(6) 6(6)
b 1(6) 6(6)
b 0(6) 0(5) 0(5)
6 0(13) 10(13) 1(24) 0(24) 0(24) 3(24)
a 0(21) 20(21)
b
68 0(5) 5(5) 0(5) 0(5) 4(5)
b 0(5) 0(4) 1(4)
73 0(6) 4(6) 0(6) 0(6) 0(6) 0(6) 0(3) 0(3)
75 0(12) 7(12) 32(40)
b 2(40) 0(40)
a 0(40) 1(37) 0(37)
a
77 0(8) 6(8) 0(10) 0(10) 8(10)
b 0(10) 0(7) 0(7)
78 0(1) 1(1) 0(1) 0(1) 0(1) 0(1) 0(1) 0(1)
81 0(2) 0(2) 0(2) 0(2) 1(2) 0(2) 1(1)
b 0(1)
82 0(1) 1(1) 0(1) 0(1) 0(1) 0(1) 0(1) 0(1)
85 0(1) 0(1) 0(1) 0(1) 0(1) 0(1) – –
87 0(4) 3(4) 0(4) 0(4) 0(4) 0(4) 0(1) 0(1)
89 0(6) 6(6) 0(7) 0(7) 0(7) 0(7) 0(4) 0(4)
9 0(2) 1(2) 0(2) 0(2) 1(2) 0(2) – –
94 0(2) 0(2) 1(2) 0(2) 1(2) 0(2) – –
Observed rates of antibiotic resistance and scarlet fever exotoxin gene carriage
for all identified sequence-based emm types. N+(N)=Number of Positives
(Number Tested). Bold indicates 50% or greater rates of resistance. Positives
either carry a particular spe gene or show resistance to a particular antibiotic
(inclusive of both intermediate and full resistance). ERY, erythromycin; CLI,
clindamycin; TET, tetracycline; LEV, levofloxacin; CHL, chloramphenicol; OFX,
ofloxacin.
aIndependently significant specific association, positive or negative.
bSignificant after alpha (Bonferroni) adjustment for multiple measures (highly
significant). speA, scarlet fever exotoxin gene A; speC, scarlet fever exotoxin
gene C. These following results are not shown in the table: 100% of tested
isolates (in all cases N.300) were susceptible to penicillin (PEN), vancomycin
(VAN), cefepime (CPM), cefotaxime (CTX), ceftriaxone (CTR), linizolid (LNZ),
meropenem (MEM), and gatifloxacin (GAT). 311 were tested with quinupristin-
dalfopristim (SYN) and one was resistant, six isolates were tested with
trovafloxacin (TVA) and 3 were resistant.
doi:10.1371/journal.pone.0006897.t003
Inference of GAS Phenotype
PLoS ONE | www.plosone.org 4 September 2009 | Volume 4 | Issue 9 | e6897standard methods by on-site clinical laboratories. Positive GAS
isolates were resuspended in tryptic soy broth with 15% glycerol,
frozen at 270uC, then shipped to the Naval Health Research
Center (NHRC) on dry ice for confirmation and testing. Samples
were stored at NHRC at 270uC.
Prior to testing, samples were re-streaked on blood agar plates (5%
sheepbloodinTSAbase)(HardyDiagnostics,SantaMaria,CA),and
incubated at 35–37uC with 5–10% CO2. After 18–24 hours of
incubation, b-hemolytic colonies were chosen, re-streaked for
isolation, and tested for Gram stain phenotype, bacitracin sensitivity
(A-disk method, Hardy Diagnostics) and positive GAS latex
agglutination reaction (Hardy Diagnostics). Confirmed GAS isolates
were then archived, and aliquots were tested for AbR and strain type.
Antibiotic resistance testing
From January 2002 through July 2006, MIC supplemental III
Panels (Becton, Dickinson and Co., Franklin Lakes, NJ) were used.
For the remaining period, the BD Phoenix test system and the
associated Streptococci test panel (Becton, Dickinson) were used.
Both systems were used per manufacturers’ instructions. For both
systems, MIC values were converted to the categorical resistance
values ‘‘resistant,’’ ‘‘intermediate,’’ or ‘‘sensitive’’ based on the
standards set by the National Committee for Clinical Laboratory
Standards (NCCLS) (which became the Clinical and Laboratory
Standards Institute [CLSI] during the study period) and the two
systems were rigorously cross-validated with identical samples to
support comparability of the results. Full resistance and interme-
diate resistance, as defined by NCCLS, were both considered
‘‘resistant’’ for the purposes of presentation and statistical analysis.
Strain typing
PCR/ESI-MS emm groups were generated for all 802 samples.
A subset of 387 of these was tested for emm type by sequencing. We
initially sequenced one isolate of each PCR/ESI-MS emm group
Table 4. Isolate properties by PCR/ESI-MS emm group.
PCR/ESI-MS emm group speA speC ERY CLI TET LEV CHL OFX
N+(N) N+(N) N+(N) N+(N) N+(N) N+(N) N+(N) N+(N)
1 14(15) 0(15) 0(38)
a 0(38) 0(38) 0(38) 2(27) 2(27)
1/4/9/15/18/39/103/110/119 – 3(4) 0(6) 0(6) 2(6)
a 0(6) 0(2) 0(2)
11 0(9) 9(9) 2(16) 3(16)
b 2(16) 0(16) 0(14) 0(14)
12/77 0(9) 6(9) 5(25) 3(24)
a 0(25) 0(25) 1(12) 0(12)
12/77/118 0(24) 22(24) 0(64)
b 0(64) 8(64)
b 0(64) 0(23) 0(23)
17/22/47/84 0(3) 1(3) 1(10) 0(10) 0(10) 0(10) 0(10) 0(10)
18/81/109 2(10) 9(10) 0(56)
b 0(56) 0(56) 1(56) 0(2) 0(2)
2 6(6) 5(6) 0(14) 0(14) 0(14) 0(14) 0(7) 0(7)
22/25/28/75 1 (1) 1 (1) 1(1) 0(1) 0(1) 0(1) 1(1) 0(1)
22/28 0(11) 10(11) 1(26) 0(26) 0(26) 0(26) 1(17) 1(17)
22/61/81/104 0(1) 1(1) 0(1) 0(1) 0(1) 0(1) – –
25/75 0(7) 6(7) 66(73)
b 2(72) 0(73) 0(73) 2(70)
a 1(70)
a
29/53/91/101 0(3) 0(3) 0/(6) 0(6) 0(6) 0(6) – –
3 0(12) 5(12) 0(132)
b 0(132) 0(132)
a 3(132) 16(107)
a 3(106)
a
36/77/82/85/96/103 0(1) 0(1) 0(1) 0(1) 0(1) 0(1) – –
4 0(12) 9(12) 4(27) 1(27) 0(27) 0(27) 0(9) 0(9)
5/58 0(39) 34(39) 11(188)
a 4(188) 8(188) 0(188) 13(81)
a 0(81)
b
52/93/101/104/116 0(1) 1(1) 0(4) 0/(4) 0(4) 0(4) – –
6 0(1) 1(1) 1(1) 0(1) 0(1) 0(1) 0(1) 1(1)
6/22/50/62/81/104 0(11) 8(11) 0(36)
a 0(36) 0(36) 3(36)
b 1(34) 33(34)
b
68/75 0(11) 7(11) 0(13) 0(13) 6(13)
b 0(13) 0(10) 1(10)
73/81/90 0(6) 4(6) 0(8) 1(8) 0(8) 0(8) 0(3) 0(3)
75/78/89 0(6) 6(6) 0(14) 0(14) 0(14) 0(14) 0(4) 0(4)
78 0(1) 1(1) 0/(2) 0(2) 0(2) 0(2) 0(2) 0(2)
87 0(4) 3(4) 0(5) 0(5) 0(5) 0(5) 0(2) 0(2)
9/44/61/82 0(8) 1(8) 1(28) 0(28) 1(28) 0(28) 6(21)
a 0(21)
94 0(3) 0(3) 1(3) 0(3) 2(3)
a 0(3) 1(2) 0(2)
Observed rates of antibiotic resistance and scarlet fever exotoxin gene carriage for all identified PCR-ESI/MS emm groups. N+(N)=Number of Positives (Number Tested).
Bold indicates 50% or greater rates of resistance. Positives either carry a particular spe gene or show resistance to a particular antibiotic (inclusive of both intermediate
and full resistance). ERY, erythromycin; CLI, clindamycin; TET, tetracycline; LEV, levofloxacin; CHL, chloramphenicol; OFX, ofloxacin.
aIndependently significant specific
association, positive or negative.
bSignificant after alpha (Bonferroni) adjustment for multiple measures (highly significant). speA, scarlet fever exotoxin gene A; speC,
scarlet fever exotoxin gene C. These following results are not shown in the table: 100% of tested isolates (in all cases N.300) were susceptible to penicillin (PEN),
vancomycin (VAN), cefepime (CPM), cefotaxime (CTX), ceftriaxone (CTR), linizolid (LNZ), meropenem (MEM), and gatifloxacin (GAT). 311 were tested with quinupristin-
dalfopristim (SYN) and one was resistant, six isolates were tested with trovafloxacin (TVA) and 3 were resistant.
doi:10.1371/journal.pone.0006897.t004
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Correlation data were used to generate a translation matrix for
inference of specific emm types from the PCR/ESI-MS data. One
hundred and eighty-eight further isolates were sequenced to
estimate consistency within clusters.
emm sequencing
The sequencing procedure was adapted, using optimized cycling
conditions and PCR reagents, from a Centers for Disease Control
and Prevention protocol (http://www.cdc.gov/ncidod/biotech/
strep/protocol_emm-type.htm). Extraction was performed with
theQIAamp 96DNAbloodkit(QIAGEN, Valencia,CA). Products
were processed with an ABI Prism 3100 sequencer (Applied
Biosystems, Foster City, CA). Sequences were analyzed with
Lasergene (DNASTAR, Inc., Madison WI) and submitted to the
CDC BLAST-emm server (http://www.cdc.gov/ncidod/biotech/
strep/strepblast.htm) to obtain emm type match information.
PCR/ESI-MS
Grown isolates were diluted 10-fold in the DNA Dilution Buffer
provided in the GAS Genotyping Kit (Ibis Biosciences, Inc.,
Carlsbad, CA) and boiled at 100uC for 10 min. Automated PCR
setup was done on the Janus Liquid Handling Station (PerkinEl-
mer, Inc., Waltham, MA). Five microliters of enzyme mix,
containing GAS Kit PCR Enzyme Dilution Buffer (Ibis Biosci-
ences), 2.4 U/rxn FastStart Taq DNA Polymerase (Roche,
Indianapolis, IN), and 5 ml of template were added to each well
of a GAS Genotyping plate (Ibis Biosciences). PCR cycling
conditions were as follows: 95uC for 10 min; followed by 8 cycles
of 95uC for 30 sec, 48uC for 30 sec with an increase of 0.9uC per
cycle, and 72uC for 30 sec; then 37 cycles of 95uC for 15 sec, 56uC
for 20 sec, and 72uC for 20 sec. Final extension was performed at
72uC for 2 min followed by a 4uC hold. PCR was performed on a
Bio-Rad DNA Engine (Bio-Rad Laboratories, Hercules, CA).
Primer design and sequence information is available elsewhere [7].
Post-PCR desalting, mass spectrometer analysis and emm type
analysis were performed on the Ibis T5000 platform (Ibis
Biosciences), as previously described [7].
Statistical analysis
Accuracy of PCR/ESI-MS inference was measured in terms of
the proportion of PCR/ESI-MS emm group identities that included
the correct emm sequence type. Both PCR/ESI-MS emm groups
and directly sequenced emm types were independently analyzed for
correlation with AbR measures over the course of study. The
nonrandomness of the distribution of each type of AbR across all
emm types (and groups) was measured by chi-square analysis. The
significance of specific genotype:phenotype associations were
measured by binomial probability analysis of the observed
distributions of resistance for specific genotypes for each type of
resistance, with appropriate alpha adjustment for multiple
measures across all strain types.
spe testing
Representatives of all identified emm types were tested for speA
and speC by nested PCR [19]. DNA amplification was performed
as referenced [19], except for the following changes: the reaction
volume was reduced from 50 mlt o2 5 ml, and the annealing
temperature was reduced from 57uC for 1 min to 55uC for 45 sec.
The reaction volume and cycling conditions were adjusted and
optimized for use with the GoTaq Flexi DNA Polymerase and
buffer system (Promega BioSciences, San Luis Obispo, CA, USA).
Thermal cycling was performed on a Bio-Rad DNA Engine (Bio-
Rad).
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Table 5. Rates and significance of nonrandom distribution by
sequenced emm type.
Antibiotic ERY CLI TET LEV OFX CHL
N tested 386 386 386 386 261 261
#resistant
a 48 6 36 5 26 21
% resistant 12% 1.5% 9.3% 1.3% 10% 8.1%
p (Pearson) ,0.001 0.1 ,0.001 0.4 ,0.001 0.1
Overall rate of antibiotic resistance among all GAS emm types, and the
significance of nonrandom association between emm type and antibiotic
resistance.
aIncludes both intermediate and fully resistant isolates, as per CLSI
definitions. p values represent the probability that the observed distribution of
resistance among the types resulted from a random distribution among the real
population. Pearson tests were run using Monte Carlo method; N=10,000.
ERY, erythromycin; CLI, clindamycin; TET, tetracycline; LEV, levofloxacin; OFX,
ofloxacin; CHL, chloramphenicol.
doi:10.1371/journal.pone.0006897.t005
Table 6. Rates and significance of nonrandom distribution by
PCR/ESI-MS emm group.
Antibiotic ERY CLI TET LEV OFX CHL
N tested 798 796 798 798 460 461
#resistant
a 94 13 28 6 42 44
% resistant 12% 1.6% 3.5% 0.75% 9.1% 9.5%
p (Pearson) ,0.0001 0.02 ,0.0001 0.2 ,0.0001 0.01
Overall rate of antibiotic resistance among all GAS emm groups, and the
significance of nonrandom association between emm group and antibiotic
resistance.
aIncludes both intermediate and fully resistant isolates, as per CLSI
definitions. p values represent the probability that the observed distribution of
resistance among the types resulted from a random distribution among the real
population. Pearson tests were run using Monte Carlo method; N=10,000.
ERY, erythromycin; CLI, clindamycin; TET, tetracycline; LEV, levofloxacin; OFX,
ofloxacin; CHL, chloramphenicol.
doi:10.1371/journal.pone.0006897.t006
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